There are species differences between human histamine H 1 receptor (hH 1 R) and guinea pig (gp) histamine H 1 receptor (gpH 1 R) for phenylhistamines and histaprodifens. Several studies showed participation of the second extracellular loop (E2-loop) in ligand binding for some G protein-coupled receptors (GPCRs). Because there are large species differences in the amino acid sequence between hH 1 R and gpH 1 R for the N terminus and E2-loop, we generated chimeric hH 1 Rs with gp E2-loop (h gpE2 H 1 R) and gp N terminus and gp E2-loop (h gpNgpE2 H 1 R). hH 1 R, gpH 1 R, and chimeras were expressed in Sf9 insect cells. [
G protein-coupled receptors (GPCRs) represent the largest class of cell-surface receptors, which consist of seven transmembrane helices that are connected by three extracellular and three intracellular loops (Kristiansen, 2004 ). The histamine H 1 receptor (H 1 R) is a biogenic amine receptor that belongs to class I of the GPCRs (Foord et al., 2005) , and it interacts with G q proteins to activate phospholipase C (Hill et al., 1997) .
In histaprodifens (Fig. 1) , identified as potent H 1 R agonists at the guinea pig (gp) ileum (Elz et al., 2000; Menghin et al., 2003) , a 3,3-diphenylpropyl moiety is combined with a 2-substituted histamine. A pharmacological characterization of histaprodifens at the human H 1 R (hH 1 R) and guinea pig H 1 R (gpH 1 R) showed significant species differences Straßer et al., 2008) . Several amino acids are involved in histamine binding: Asp 3.32 (Ohta et al., 1994; Nonaka et al., 1998) , Lys 5.39 (Leurs et al., 1995; Bruysters et al., 2004; Jongejan and Leurs 2005) , Thr 5.42 and Asn 5.46 (Leurs at al., 1994; Ohta et al., 1994) , and Phe 6.55 (Bruysters et al., 2004) . The amino acid side chains Trp 4.56 , Lys 5.39 , Phe 6.52 , and Phe 6.5 were found to interact with H 1 R antagonists (Wieland et al., 1999; Gillard et al., 2002) . Asn 2.61 acts as a selectivity switch between hH 1 R and gpH 1 R for suprahistaprodifen and dimeric histaprodifen (Bruysters et al., 2005) . However, pharmacological analysis of suprahistaprodifen and dimeric histaprodifen at the bovine H 1 R and the rat H 1 R (Straßer et al., 2008) showed that the amino acid in position 2.61 cannot be exclusively responsible for the observed species differences.
Molecular modeling studies of dimeric histaprodifen in the binding pocket of the gpH 1 R suggest that the second extracellular loop (E2-loop) is in close contact to dimeric hista-prodifen and suprahistaprodifen and participates in binding of large ligands by forming hydrogen bonds (Straßer et al., 2008) . Furthermore, the N terminus presumably interacts with the E2-loop. Comparing the amino acid sequences of the N terminus and E2-loop between hH 1 R and gpH 1 R, species differences of approximately 60% for the N terminus and of approximately 30% for the E2-loop are found (Fig. 2) .
Several studies have analyzed the contribution of the E2-loop to agonist or antagonist binding or activation of GPCRs, and the same analysis was performed with the adenosine A 1 , A 2a , A 3 receptors (Olah et al., 1994; Kim et al., 1996) , the dopamine D 2 receptor (Shi and Javitch, 2004) , the muscarinic acetylcholine M 3 receptor (Scarselli et al., 2007) , the ␣ 1 -adrenergic receptor (Zhao et al., 1996) , the ␣ 2A -adrenergic receptor (Laurila et al., 2007) , and the histamine H 2 receptor (Preuss et al., 2007) . To study the influence of the species differences in N terminus and E2-loop between hH 1 R and gpH 1 R, we constructed chimeric hH 1 R with gp E2-loop (h gpE2 H 1 R) and hH 1 R with gp N terminus and gp E2-loop (h gpNgpE2 H 1 R) (Fig. 3A) . The wild-type and chimeric H 1 Rs were coexpressed with the regulator of G protein signaling 4 (RGS4) in Sf9 insect cells. We characterized some histaprodifens ( Fig. 1 
) in [
3 H]mepyramine competition binding assay and GTPase assay. In addition, active-state models based on the crystal structure of bovine rhodopsin and ␤ 2 receptor were constructed and compared to each other.
Materials and Methods
Materials. Phusion high-fidelity polymerase, all restriction enzymes, and T4 DNA ligase were obtained from New England Biolabs (Ipswich, MA). The anti-Flag IgG (M1 monoclonal antibody) was obtained from Sigma-Aldrich (St. Louis, MO), and the anti-RGS4 was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
[␥-32 P]GTP was synthesized as described previously (Preuss et al., 2007), and [ 3 H]mepyramine (30.0 Ci/mmol) was obtained from PerkinElmer Life and Analytical Sciences (Waltham, MA). A Rotiszint ecoplus (Roth, Karlsruhe, Germany) liquid scintillation cocktail was used. Histaprodifens were synthesized as described by Elz et al. (2000) , Menghin et al. (2003), and Striegl (2006) . Construction of pGEMh gpE2 H 1 R, pGEMh gpNgpE2 H 1 R, pVLh gpE2 H 1 R, and pVLh gpNgpE2 H 1 R. First, a pGEM-3Z-SFh gpN H 1 R plasmid was constructed. Therefore, pGEM-3Z-SF-gpH 1 Rplasmid and pGEM-3Z-SF-hH 1 R plasmid were double-digested with HindIII and PflMI, resulting in the fragments h-I, h-II, gp-I, and gp-II (Fig. 3B) . The fragments h-I and gp-I were digested with PvuII, producing four fragments as follows: h-Ia, h-Ib, gp-Ia, and gp-Ib (Fig.  3B ). Fragments h-Ia and gp-Ia encode parts of the pGEM-3Z-SFplasmid, the N terminus, and the very beginning of transmembrane domain (TM) I. After separation and cleaning of the fragments, a triple ligation with gp-Ia, h-Ib, and h-II was performed. For generation of pGEM-3Z-SF-h gpE2 H 1 R and pGEM-3Z-SF-h gpNgpE2 H 1 R, overlap-extension polymerase chain reactions (PCR) (PCR Ia, PCR Ib, and PCR II) with pGEM-3Z-SF-hH 1 R and pGEM-3Z-SF-h gpN H 1 R plasmid, respectively, as template were performed. In PCR Ia, the DNA fragment with the signal peptide (S), the FLAG epitope (F), and the first part of the h gpN H 1 R up to transmembrane domain IV with guinea pig E2-loop was amplified. In PCR Ib, the DNA fragment encoding the guinea pig E2-loop, the second part of the hH 1 R, and the His 6 tag (CACCATCATCACCATCAC) was generated. In PCR II, the products of PCR Ia and PCR Ib were annealed in the gp E2-loopencoding region, resulting in PCR fragments that encode the SF, h gpNgpE2 H 1 R, the His 6 tag, the stop codon, and an XbaI site. For PCRs, the following primers targeting the E2-loop were used: GCTCACTCATTAGGCACC (forward, PCR Ia, PCR II); TTTCT-CCCGGGGCTCACTAGTCGGGGCCATGAAGTGGTGCCAGCCTA-GAATGGGAATAAC (reverse, PCR Ia); CACCACTTCATGGCCCCG-ACTAGTGAGCCCCGGGAGAAAAAGTGTGAGACAGACTTCTAT (forward, PCR Ib); and GGATCCTCTAGATTAGTGATGGTGATG-ATGGTG (reverse, PCR Ib, PCR II). The underlined code indicates a silent mutation for introduction of a unique diagnostic SpeI site. Italic letters designate the E2-loop. The resulting PCR fragment was doubledigested with HindIII and XbaI and cloned into the pGEM-3Z plasmid using pGEM-3Z-SF gpH 1 R as a template. The sequences of h gpE2 H 1 R and h gpNgpE2 H 1 R, cloned into the pGEM-3Z-SF plasmid, were checked for their correctness by sequencing (Entelechon, Regensburg, Ger- 3 . Scheme of the wild-type hH 1 R and gpH 1 R and the chimeras h gpE2 H 1 R, h gpNgpE2 H 1 R, and fragments used for construction of h gpE2 H 1 R. A, hH 1 R, black; h gpE2 H 1 R, the parts of hH 1 R are given in black, and the E2-loop according gpH 1 R is shown in gray; h gpE2gpN H 1 R, the parts of hH 1 R are given in black, and the N terminus and E2-loop according gpH 1 R are shown in gray; gpH 1 R, gray. B, the sequence of pGEM-3Z-SF-hH 1 R and pGEM-3Z-SF-gpH 1 R with PvuII, HindIII, and PflMI sites is given schematically. The fragments resulting from digestion are marked.
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at ASPET Journals on April 5, 2017 jpet.aspetjournals.org many). pGEM-3Z-SF-h gpE2 H 1 R and pGEM-3Z-SF-h gpNgpE2 H 1 R were used as a template to clone h gpE2 H 1 R and h gpNgpE2 H 1 R into the pVL1392 baculovirus transfer vector using the restriction sites BssHII and XbaI. All wild-type and chimeric H 1 Rs were N-terminally tagged with the signal peptide and FLAG epitope ATGAAGACGATCATCGC-CCTGAGCTACATCTTCTGCCTGGTATTCGCCGACTACAAGGAC-GATGATGACGCC and C-terminally tagged with the His 6 tag CAC-CATCATCACCATCAC.
Preparation of Compound Stock Solutions. Chemical structures of the analyzed compounds are given in Fig. 1 . Compounds 1 and 8 (10 mM each) were dissolved in double-distilled water. Compounds 2 to 6 were dissolved in a solvent mixture containing 30% (v/v) dimethyl sulfoxide (DMSO), 30% (v/v) Tris-HCl, pH 7.4 (10 mM), and 40% (v/v) double-distilled water, 5 mM each. Compound 7 was dissolved in 50% (v/v) DMSO and 50% (v/v) Tris/HCl, pH 7.4 (10 mM), at a concentration of 1 mM. This lead to a 1:10 dilution of DMSO in each assay tube. Reference binding and GTPase assays with three preparations of histamine dissolved in 1) double-distilled water, 2) 30% (v/v) DMSO, 30% (v/v) Tris-HCl, pH 7.4 (10 mM), 40% (v/v) double-distilled water [equivalent to a final DMSO concentration of 3% (v/v)], and 3) 50% (v/v) DMSO, 50% (v/v) Tris-HCl, pH7.4 (10 mM), equivalent to a final DMSO concentration of 5% (v/v), respectively, revealed only a decrease in the radioactivity counted, but to no shift in pK i and pEC 50 values.
Miscellaneous. Cell culture, generation of recombinant baculoviruses, and membrane preparations were performed as described in Straßer et al. (2008) . The determination of protein concentration, the SDS-polyacrylamide gel electrophoresis, and the immunoblot analysis were performed as described previously Straßer et al., 2008) . The pharmacological assays, i.e., [
3 H]mepyramine saturation binding assay, [
3 H]mepyramine competition binding assay, and steady-state GTPase assay, were performed as described previously (Straßer et al., 2008) . All assays for comparison of pharmacological data pharmacological data between the wild-type species isoforms of hH 1 R and gpH 1 R with the chimerics h gpE2 H 1 R and h gpNgpE2 H 1 R were carried out in parallel and under the same experimental conditions. All data were analyzed with Prism 4.02 (GraphPad Software Inc., San Diego, CA). pK i and pK B values were calculated according to the Cheng and Prusoff (1973) method. All data are the means Ϯ S.E.M. of at least three independent experiments. To compare two pairs of data, the significance of the deviation of zero p was calculated using the t test.
Construction of Active H 1 R Models with Dimeric Histaprodifen in the Binding Pocket. Besides the well known crystal structure of bovine rhodopsin, in recent studies, the crystal structure of an additional GPCR, namely the human ␤ 2 -adrenergic receptor (h␤ 2 AR), was solved Rasmussen et al., 2007; Rosenbaum et al., 2007) . Therefore, two homology models of gpH 1 R, based on the two different crystal structures, were generated. The generation of the gpH 1 R model based on the crystal structure of bovine rhodopsin was described previously (Straßer and Wittmann, 2007) . The gpH 1 R homology model based on the crystal structure of the h␤ 2 AR (2RH1.pdb) Rasmussen et al., 2007; Rosenbaum et al., 2007) was constructed in the same manner for all parts of the receptor, with the exception of the N terminus and E2-loop. Because of the lack of the conformation of the N terminus in the crystal structure of the h␤ 2 AR, the N terminus was adopted from the crystal structure of bovine rhodopsin. The alignment of the E2-loop was performed manually and is given in Fig. 4 . The modeling of the E2 regions His175 Ϫ Phe177, Ala179 Ϫ Pro184, and Glu190 Ϫ Tyr194 was performed using the loop-search module of the software SYBYL 7.0 (Tripos, St. Louis, MO). The helix structure of the E2-loop in the crystal structure of h␤ 2 AR was not implemented in the homology model of gpH 1 R. In the crystal structure of the h␤ 2 AR, two disulfide bridges, Cys191(E2) Ϫ Cys-184(E2) and Cys192(E2) Ϫ Cys106 (TM3, 3.25), are found. In the gpH 1 R model, only one disulfide bridge, Cys189(E2) Ϫ Cys109(TM3, 3.25), is modeled. The resulting homology model was energetically minimized and embedded in an environment consisting of 1-palmitoyl-2-oleoyl-phosphatidylcholine molecules, intracellular and extracellular water molecules, sodium, and chloride ions. Molecular dynamics (MD) simulations to generate an active gpH 1 R model based on the crystal structure of h␤ 2 R were performed in an analogous way as described previously (Straßer and Wittmann, 2007) . In the active model, a positively charged dimeric histaprodifen was docked manually and after MD simulations were performed, as described previously (Straßer et al., 2008) . Inactive and active models of hH 1 R and h gpNgpE2 H 1 R, based on the crystal structure of h␤ 2 AR, were constructed in analogy to the corresponding gpH 1 R model.
Based on the active-state models of the H 1 Rs, additional MD simulations were carried out. The equilibration phase and the productive phase were performed as described previously (Straßer et al., 2008) . For all calculations, the software package GROMACS 3.3.1 (van der Spoel et al., 2004) was used in combination with the ffG53A6 force field (Oostenbrink et al., 2004) . The force-field parameters for dimeric histaprodifen 7 were adopted from the ffG53A6 force field.
Results
Immunological Detection of the H 1 R Constructs. All H 1 R constructs were immunologically detected with the M1 antibody (Fig. 5) . hH 1 R showed a strong band at ϳ85 kDa. In contrast, gpH 1 R showed a strong band at 25 kDa, intermediate bands at ϳ30 and ϳ36 kDa, and faint bands at ϳ50 and ϳ100 kDa. For h gpE2 H 1 R, a strong band was detected at ϳ60 kDa and weak bands were detected in a range from 25 to 37 kDa. For h gpNgpE2 H 1 R, a weak band was visible at ϳ60 kDa, corresponding to h gpE2 H 1 R. The ϳ60-kDa band of the chimeric constructs h gpE2 H 1 R and h gpNgpE2 H 1 R corresponds very well to the theoretical mass of ϳ56 kDa. The increase by 4 kDa relative to the theoretical mass is probably due to N-glycosylation. However, both chimeric constructs show different behavior with respect to the wild-type species isoforms, namely hH 1 R and gpH 1 R. These experimental results may be explained with different N-glycosylation states. At the N terminus, hH 1 R exhibits two and gpH 1 R exhibits one glycosylation site(s). Homology models of H 1 Rs suggest that there is one additional N-glycosylation site for hH 1 R in the E2-loop, but not for gpH 1 R. Thus, hH 1 R exhibits three (h gpE2 H 1 R two, h gpNgpE2 H 1 R one, and gpH 1 R one) glycosylation site(s).
Analysis Table 1 . There was no significant difference in the K D values of hH 1 R, h gpE2 H 1 R, and h gpNgpE2 H 1 R, which were 1.5 to 2-fold higher (p Ͻ 0.05) than at gpH 1 R. The B max value for h gpE2 H 1 R was in the same range as the value for hH 1 R. The B max value for h gpNgpE2 H 1 R was approximately 3-fold lower (p Ͻ 0.05) than that of h gpE2 H 1 R, corresponding to the weaker immunoreactivity in the immunoblot (Fig. 5) Table 2 . For compounds 1 to 4S and 7, no significant difference in pK i values was found between hH 1 R, h gpE2 H 1 R, and h gpNgpE2 H 1 R. However, for phenoprodifen 5 as well as for the chiral phenoprodifens 6R and 6S, a significant decrease in pK i values was found in the series hH 1 R Ͼ h gpE2 H 1 R Ն h gpNgpE2 H 1 R (Fig. 6 ). For compound 5 at hH 1 R, the pK i value was significantly (p Ͻ 0.005) higher than at h gpE2 H 1 R and h gpNgpE2 H 1 R. At hH 1 R, the pK i value of 6R was significantly lower than that of 6S (p Ͻ 0.05).
Constitutive Activity and Maximal Stimulation with Histamine of hH 1 R, h gpE2 H 1 R, h gpNgpE2 H 1 R, and gpH 1 R. The H 1 R couples to endogenous G q proteins of Sf9 insect cells (Houston et al., 2002) . Agonist activation of the G q proteins is detected by an increase of high-affinity GTP hydrolysis in membranes expressing H 1 R and RGS proteins. The basal GTPase activity of the wild-type and chimeric H 1 R species ranged from 1.1 to 1.5 pmol/(mg‫ء‬min) without significant differences (Table 3) . However, the maximal stimulation with 100 M histamine 1 relative to the basal activity (⌬HA) at h gpNgpE2 H 1 R was significantly higher (p Ͻ 0.005) than at hH 1 R, h gpE2 H 1 R, and gpH 1 R (Table 3 ). In addition, the ratio ⌬HA/B max was significantly higher (p Ͻ 0.01) at h gpNgpE2 H 1 R than at hH 1 R, h gpE2 H 1 R, and gpH 1 R. Therefore, it can be concluded that the large stimulatory effect of histamine at h gpNgpE2 H 1 R, despite the low expression level of h gpNgpE2 H 1 R in Sf9 cell membranes, is a consequence of receptor conformation due to binding of the endogenous ligand histamine 1. The inverse agonist mepyramine 8 (Fitzsimons et al., 2004) , which stabilizes the inactive state of the H 1 R and consequently reduces constitutive activity , showed only small inhibitory effects on basal GTP hydrolysis at all four H 1 Rs, indicating a low constitutive activity of the wild-type and chimeric H 1 Rs (Table 3 ). The pEC 50 values of mepyramine 8 ranged from 7.75 to 8.96 (Table 3 ). There was no significant difference between the pEC 50 values of mepyramine between hH 1 R and the chimeric H 1 Rs, but the pEC 50 values at the chimeric H 1 Rs were significant lower (p Ͻ 0.005) than at gpH 1 R.
Analysis of Histaprodifens at H 1 R Wild-Type and Chimeric Species Isoforms in the Steady-State GTPase Assay. The potencies and efficacies (Table 4) , and the pK B values (Table 5) , determined in the steady-state GTPase assay are given. A decrease in pEC 50 values of histamine 1 in the series hH 1 R Ͼ h gpE2 H 1 R Ͼ h gpNgpE2 H 1 R was observed (Fig. 7) . The potency of 1 at h gpE2 H 1 R and h gpNgpE2 H 1 R was significantly lower than hH 1 R (p Ͻ 0.05 for h gpE2 H 1 R and p Ͻ 0.005 for h gpNgpE2 H 1 R). For compounds 2 to 4S and 7, neither differences in potency nor efficacies were found between hH 1 R and both chimeras. For the phenoprodifen 5, a decrease in potency was found in the series hH 1 R Ͼ h gpE2 H 1 R Ͼ h gpNgpE2 H 1 R. The chiral phenoprodifens 6R and 6S act as antagonists at h gpE2 H 1 R and h gpNgpE2 H 1 R as well as at hH 1 R (Straßer et al., 2008) . In accordance with the results in the competition binding (Fig. 6 ) assay, a decrease in pK B values was found for 6R as well as for 6S in the series hH 1 R Ͼ h gpE2 H 1 R Ͼ h gpNgpE2 H 1 R (Table 4) .
Binding Mode of Dimeric Histaprodifen in gpH 1 R Models Based on Two Different Crystal Structures.
The binding mode of dimeric histaprodifen 7 docked into the binding pocket of the gpH 1 R active-state model, based on the crystal structure of bovine rhodopsin (Fig. 8A) , was described in detail in Straßer et al. (2008) . In comparison, the molecular dynamics simulations with dimeric histaprodifen 7 docked into the active-state model of the gpH 1 R, based on the crystal structure of h␤ 2 AR (Fig. 8B) , revealed some differences in the resulting binding mode. The largest difference between the two active gpH 1 R models were found in the conformation and flexibility (Fig. 9 ) of the E2-loop. In the bovine rhodopsin-based gpH 1 R model, the part of the E2-loop that shows species differences between hH 1 R and gpH 1 R is in close contact to the upper part of the binding pocket, near the transmembrane domain II. It is interesting to note that the backbone carbonyl of Lys187 (gpH 1 R) forms a hydrogen bond to an imidazole moiety of dimeric histaprodifen. Because of a shift of the E2-loop in the h␤ 2 AR-based model, Lys187 does (Fig. 8 ). Both dipenyl propyl moieties of the dimeric histaprodifen are embedded in hydrophobic pockets. The conserved disulfide bond between two cysteine side chains in TM3 and the E2-loop is responsible for a reduced flexibility in this region of the E2-loop (Fig. 9) . However, although molecular dynamic simulations show a high flexibility of the nonrestricted parts of the E2-loop, a movement toward the binding pocket is notably observed. The interaction between the conserved Glu and the ligand is observed only in cases where the E2-loop is close to the binding pocket. This hydrogen bond stabilizes the conformation of the ligand in the binding pocket and reduces the flexibility of the ligand. The exchange of N terminus and E2-loop exerted an influence onto the hydrogen bond network between N terminus, E1-loop, and E2-loop with an effect on E2-loop conformation and flexibility (Fig. 9 ).
Discussion
GTPase Activation and Potency of Histamine at the Chimeric h gpNgpE2 H 1 R Compared with hH 1 R. Our steady-state GTPase assay data show that the double-chimeric h gpNgpE2 H 1 R has influence on the maximal G q -protein stimulation with histamine and potency of histamine, compared with hH 1 R. Because the single-chimeric h gpE2 H 1 R showed no influence on the maximal G q -protein stimulation with histamine compared with hH 1 R, it can be concluded that the N terminus or the N terminus in combination with the E2-loop is responsible for this observation. Molecular dynamics simulations revealed that the exchange of N terminus and E2-loop has an influence on the hydrogen bond network between N terminus, E1-loop, and E2-loop with an effect on the conformation and flexibility of the E2-loop. Based on these data, it can be concluded that the interaction of the N terminus with the extracellular parts of the receptor induces subtle long-range conformational changes, resulting in a larger stimulatory effect of histamine and a decreased potency at h gpNgpE2 H 1 R compared with hH 1 R.
Influence of the N Terminus and E2-Loop on Pharmacological Differences of Histaprodifens between hH 1 R and gpH 1 R. The experimental data show that the chimeric Data were analyzed by nonlinear regression and were best fit to one-site (monophasic) competition curves. The downwardfacing triangle () shows the data for hH 1 R, and the square (f) shows the data for the chimerical h gpNgpE2 H 1 R. Data shown are the means Ϯ S.E.M. of at least three experiments, each one performed in duplicate. Membranes were used from independent membrane preparations.
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h gpE2 H 1 R and h gpNgpE2 H 1 R are well expressed in Sf9 cell membranes and show full functionality. However, the pharmacological studies specifically binding assays and steady-state GTPase assays indicate that the N terminus and the E2-loop are not responsible for the species differences between hH 1 R and gpH 1 R with regard to pK i , pEC 50 , and E max values for compounds 2 to 4S and 7. Nevertheless, for the three phenoprodifens (5, 6R, and 6S) with a high structural similarity, a significant decrease in pK i and pEC 50 values was found in the series hH 1 R Ͼ h gpE2 H 1 R Ͼ h gpNgpE2 H 1 R.
Our molecular dynamics simulations with the new gpH 1 R model, based on the crystal structure of h␤ 2 AR, show that the backbone carbonyl of Lys187 (gpH 1 R) is far away from the binding pocket and does not interact with a large histaprodifen in the binding pocket, as suggested by the gpH 1 R model based on the crystal structure of bovine rhodopsin. In addition, the molecular dynamic simulations based on the h␤ 2 AR model show that the highly conserved Glu181 (hH 1 R) and Glu190 (gpH 1 R), respectively, within the H 1 R family point toward the binding pocket with formation of a stable hydrogen bond to the ligand and point away from the binding pocket forming a stable hydrogen bond to Tyr96 (TM2, 2.42). The MD simulations have shown that the exchange of the N terminus and E2-loop exhibits an influence of the hydrogen bond network in the extracellular part of the receptor with an effect on E2-loop conformation and flexibility, which results in decreased pK i and pK B values for the phenoprodifens 5, 6R, and 6S at the chimeric H 1 Rs. Furthermore, we assume that 5, 6R, and 6S can bind in two different orientations into the binding pocket (Straßer et al., 2008) . It is possible that a change in orientation of 5, 6R, and 6S in the series hH 1 R Ϫ h gpE2 H 1 R Ϫ h gpNgpE2 H 1 R can explain our experimental data. Because the largest differences between hH 1 R, the chimeric H 1 Rs, and gpH 1 R occur in the extracellular surface of the receptor, it is assumed that this possible change in orientation is determined kinetically during the early steps of the ligand binding process. To test this hypothesis, sophisticated kinetic binding studies have to be carried out. Furthermore, extensive molecular dynamics simulations with compounds TABLE 3 Analysis of the effects of histamine and mepyramine and determination of the constitutive activity of hH 1 R, h gpE2 H 1 R, h gpNgpE2 H 1 R, and gpH 1 R in the steady-state GTPase assay Sf9 cell membranes expressing hH 1 R, h gpE2 H 1 R, h gpNgpE2 H 1 R, or gpH 1 R in combination with RGS4 were used to study the constitutive activity. GTPase assays were performed as described under Materials and Methods. The concentration-response curves of the inverse agonist MEP (8) were determined in a concentration range from 0.1 to 10 M. Data were analyzed by nonlinear regression and were best fit to sigmoidal concentration-response curves. The efficacy of histamine was set 1.00. The ⌬HA value refers to the difference of maximal stimulation with 100 M histamine relative to basal activity. The coefficient ⌬HA/B max was calculated based on the data given for ⌬HA in this The potencies of 4S, 6R, and 6S were determined in the steady-state GTPase assay as described under Materials and Methods. Each assay tube additionally contained 1 M histamine. Data were analyzed by nonlinear regression and were best fit to sigmoidal concentration-response curves. The pK B values were calculated according to Cheng and Prusoff (1973) Our new H 1 R models indicate that the region of the E2-loop with species differences in amino acid sequence is pointing away from the binding pocket. It is possible that highly conserved amino acids in the E2-loop of H 1 Rs are involved in ligand binding, e.g., Glu190 (E2-loop, gpH 1 R), which shows electrostatic interaction with dimeric histaprodifen in the old gpH 1 R model as well as in the new model. Additional experimental studies will be carried out to analyze the participation of Glu190 (E2-loop, gpH 1 R) in binding of large histaprodifens.
Role of the Extracellular Loop E2 in Ligand Binding and Activation of GPCRs. Compared with other GPCR regions, relatively little attention has been paid thus far to the contribution of the second extracellular loop E2 in ligand recognition and ligand binding in biogenic amine and nucleoside GPCRs. Glutamate residues in the E2-loop of the human A 2a adenosine receptor are indirectly or directly involved in ligand binding (Kim et al., 1996) . For the ␣ 1 -adrenergic receptor, amino acids, located in the extracellular loop E2, play a role in subtype-selective antagonist binding (Zhao et al., 1996) . In addition, the affinity of yohimbine to the ␣ 2A -adrenergic receptor is significantly influenced by interactions with the extracellular loop E2 (Laurila et al., 2007) . Moreover, specific residues of the E2-loop are directly involved in forming the binding pocket of the dopamine D 2 receptor (Shi and Javitch, 2004) . For the muscarinic M 3 receptor, several amino acids in the E2-loop are important for efficient agonist-induced activation of the muscarinic M 3 receptor (Scarselli et al., 2007) . In contrast to these results, the E2-loop does not contribute to the species selectivity of guanidine-type agonists at human and guinea pig histamine H 2 receptor (Preuss et al., 2007) . Our present study shows that the E2-loop and the E2-loop in combination with the N terminus have ligand-specific influence on the pharmacology of the H 1 R. Based on these data, it can be concluded that the extracellular loop E2 as well as the N terminus contribute to ligand binding, receptor activation, and selectivity in biogenic amine and nucleoside GPCRs. Therefore, it seems to be Fig. 7 . Concentration-response curves for histamine 1 at hH 1 R, h gpE2 H 1 R, and h gpNgpE2 H 1 R in the steady-state GTPase assay. The experiments were performed using Sf9 cell membranes coexpressing hH 1 R, h gpE2 H 1 R, or h gpNgpE2 H 1 R and RGS4 as described under Materials and Methods. The downward-facing triangle () shows the data for hH 1 R, and the square (f) shows the data for the chimerical h gpNgpE2 H 1 R. Data shown are the means Ϯ S.E.M. of at least three experiments, each one performed in duplicate with independent membrane preparations. . This part of the E2-loop, which shows large species differences and is in no contact with the binding pocket, exhibits a decrease in backbone fluctuation within the series hH 1 R Ͼ h gpNgpE2 H 1 R Ͼ gpH 1 R (region between the labels E2-start and Cys-Cys). The region of the E2-loop with no species differences and contact to the ligand in the binding pocket shows a higher fluctuation for the h gpNgpE2 H 1 R compared with the wild-type H 1 Rs. For all species, the fluctuation is reduced in the region of the disulfide bridge (Cys-Cys). All calculations were performed with GROMACS 3.3.1. worthwhile to study the influence of N terminus and E2-loop on pharmacology and functionality of GPCRs in more detail.
Conclusion
Our studies have shown that the N terminus and E2-loop have ligand-specific influence onto the pharmacology of the H 1 R. For a new class of histaprodifens, the phenoprodifens 5, 6R, and 6S and the pK i and pEC 50 values (determined at hH 1 R and the chimeric h gpE2 H 1 R and h gpNgpE2 H 1 R) are not increased in direction of the gpH 1 R but decreased to the contrary direction. Thus, despite the decrease in species differences in the amino acid sequence between hH 1 R and gpH 1 R, in the series hH 1 R 3 h gpE2 H 1 R 3 h gpNgpE2 H 1 R 3 gpH 1 R, the differences in pharmacology increased for the phenoprodifens.
